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Abstract
Stable isotopes have been used to trace atoms through metabolism and quan-
tify metabolic fluxes for several decades. Only recently non-targeted stable
isotope labeling approaches have emerged as a powerful tool to gain biological
insights into metabolism. However, the manual detection of isotopic enrich-
ment for a non-targeted analysis is tedious and time consuming. To overcome
this limitation, the non-targeted tracer fate detection (NTFD) algorithm for
the automated metabolome-wide detection of isotopic enrichment has been
developed. NTFD detects and quantifies isotopic enrichment in the form of
mass isotopomer distributions (MIDs) in an automated manner, providing
the means to trace functional groups, determine MIDs for metabolic flux
analysis, or detect tracer-derived molecules in general. Here, we describe the
algorithmic background of NTFD, discuss practical considerations for the
freely available NTFD software package, and present potential applications
of non-targeted stable isotope labeling analysis.
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1. Introduction
Since the recognition of cellular metabolism as a potential intervention
point to treat complex diseases, stable isotope-assisted metabolomics tech-
niques have emerged as a valuable tool to analyze intracellular fluxes [1]. Sta-
ble isotope labeled tracers have been successfully applied to study metabolic
fluxes in cell culture and in vivo in animals and humans [2–7].
In the past such analyses have been rather targeted, mainly because iso-
topic enrichment from stable isotopes is not as readily detected as, for ex-
ample, enrichment from radioactive isotopes. After a stable isotope labeling
experiment, isotopic enrichment is typically determined by comparing the
mass isotopomer distribution (MID) observed by mass spectrometric analy-
sis with the MID to be expected from known natural isotope abundances [8].
However, to determine the theoretical MID, knowledge of the elemental com-
position of the compound of interest is required [9]. For this reason, usually
only a predefined list of compounds is analyzed for isotopic enrichment.
It is self-evident that such a targeted approach is suited to test a well de-
fined hypothesis, but fails to generate knowledge on unknown or unexpected
parts of the metabolic network. Although many metabolic pathways are well
described and known since many years, new reactions are continuously being
identified, [10, 11] underlining the necessity for a global detection of isotopic
enrichment. Recently, several tools for the non-targeted detection of isotopic
enrichment in mass spectrometric data have been developed [12–18].
Alternatively, isotopic enrichment can be determined using isotope ra-
tio mass spectrometry (IRMS) [19] with high precision in a non-targeted
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manner. Unlike conventional mass spectrometric methods, IRMS cannot be
used to determine MIDs. However, MIDs can provide interesting insights
into metabolism and are the basis for 13C-metabolic flux analysis (13C-MFA)
[20, 21].
Here we will present the non-targeted tracer fate detection (NTFD) al-
gorithm [12] which is able to detect and quantify isotopic enrichment in
GC-EI-MS data in a non-targeted manner. We will introduce the theoretical
background necessary to obtain meaningful results, discuss practical consid-
erations, and present potential applications of non-targeted stable isotope
labeling analysis.
< < < < <
NOTE TO TYPESETTER – PLACE THIS TEXT INTO A TEXT BOX
Isotopic isomers
Stable isotope labeling leads to isotopic isomerism. Usually, the following
classes of isotopic isomers are distinguished:
Isotopologues The widest class of isotopic isomers. Isomers that differ
only in their isotopic composition with otherwise identical structure,
including isotopic substitutions of different elements [22]. For example
[U-13C]acetate ([1,2-13C2]acetate), [1-13C]acetate, and [2,2,2-D3]acetate
are isotopologic. In carbon labeling experiments, the term is often
implicitly used to only refer to 13C-isotopologues.
Mass isotopomers Mass isotopomers are groups of isotopologues of the
same nominal mass or of isotopologues that cannot be separated by
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mass spectrometry [23]. Mass isotopomers are referred to as Mi, Mi,
orM+i, where i indicates the increase in nominal mass as compared to
the lightest isotopologue. For example, for carbon labeling of acetate,
M1 comprises [1-13C]acetate and [2-13C]acetate.
Isotopomers Isotopomers are isotopologues with the same isotopic sub-
stituents but in varying positions [24]. For example, [1-13C]acetate and
[2-13C]acetate, but not [1,2-13C2]acetate are isotopomeric. Isotopomers
cannot be separated by mass spectrometry.
MID The mass isotopomer distribution (MID) is the relative abundance of
the different mass isotopomers of a molecule. MIDs can be determined
from mass spectrometric measurements and are often the basis for 13C-
MFA, a method for metabolic flux analysis based on stable isotope
labeling and stoichiometric modeling, where a set of fluxes through a
predefined metabolic network is determined that can best explain the
experimentally observed isotopic labeling.
> > > > >
2. Theoretical background
2.1. Overview
Before discussing experimental and analytical considerations for the use
of NTFD, we will provide the theoretical background for the non-targeted
detection and quantification of isotopic enrichment that is necessary for the
4
user to obtain meaningful results from NTFD. After the theoretical intro-
duction we will explain which parameters of the NTFD implementation[13]
are critical for each stage.
The NTFD algorithm operates on data from two MS measurements, one
of an isotopically enriched (“labeled”) and one of a non-enriched (“unlabeled”)
sample. After peak picking and mass spectral deconvolution, the mass spec-
trum of each compound from the labeled sample is paired with its counterpart
from the unlabeled sample. Isotopically enriched compounds and mass spec-
trometric fragments are detected from the differences in these mass spectra
and the isotopic enrichment is quantified (Figure 1). Along with the MID
calculation, certain measures are determined to judge the quality of the ob-
tained MID results.
The current NTFD software is designed to analyze low resolution GC-
MS data. For high resolution LC-MS data, there are other tools available.
These tools are beyond the scope of this chapter and we will only provide
a short overview. Briefly, MetExtract [16] is a tool for the non-targeted
detection of signals of unlabeled and uniformly labeled metabolites in LC-
MS data. These information allow to differentiate between metabolites and
analytical noise and the isotopologue ratios can be used for relative quan-
tification of metabolite levels in two samples. However, MetExtract cannot
be used to analyze complex mixtures of isotopologues. IsoMETLIN [17] is a
web-based tool that identifies isotopologues of known compounds based on
a computationally generated database and is thus rather targeted. It cannot
identify unknown labeled metabolites. IsoMETLIN can make use of MS/MS
spectra to resolve individual isotopomers. Such information can also be ob-
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tained from NTFD by analyzing specific mass spectrometric fragments [9] or
combinations thereof [25]. MzMatch-ISO [18] and X13CMS [14] are both R
packages that allow for the non-targeted determination of MIDs and can be
regarded as the LC-MS equivalents of NTFD.
We will now discuss the NTFD algorithm for the detection and quantifi-
cation of isotopic enrichment in more detail.
2.2. Detection of isotopically enriched fragments
When a compound is isotopically enriched, its mass spectrum changes.
Assuming there are no isotope effects on ionization and fragmentation, the
relative intensities of all fragments will be conserved. However, within each
enriched isotopic peak cluster, the relative M0 intensity will decrease and
the intensity of the remaining peaks will increase as compared to the non-
enriched spectrum (Figure 2). The decrease in M0 equals the absolute value
of the summed increase in heavier mass isotopomer abundances, since we
assume that the relative fragment intensities remain constant.
These changes become more obvious in the difference spectrum where a
labeled fragment will lead to a positive peak followed by a negative peak with
the same area under the peak (Figure 2). These characteristic patterns are
used to detect all labeled fragments.
For this detection of isotopic enrichment, the mass spectra of all com-
pounds from the labeled and unlabeled sample need to be compared. There-
fore, a spectrum and retention time (or retention index) matching [26] is
performed between all mass spectra detected in the labeled and unlabeled
samples during the previous step (Figure 1). To ensure only identical com-
pounds are matched, this matching is highly stringent in terms of retention
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time and loose in terms of mass spectrum similarity. Therefore, there should
not be any significant shifts if retention times between the two measure-
ments. The loose spectrum matching will ensure that the spectra of the
labeled and unlabeled compound are also matched correctly in case of high
isotopic enrichment, which can lead to very dissimilar mass spectra of the
same compound.
In the case that replicate measurements have been provided, mass spectra
from these chromatograms are matched first. This replicate mass spectra
matching is highly stringent in terms of mass spectrum similarity, since there
should not be any differences in isotopic enrichment and, thus, the mass
spectra should be identical.
Once the mass spectra from the labeled (Irawl ) and unlabeled sample
(Irawul ) have been paired, they are analyzed for differences. Therefore, the
peak intensities across the whole mass spectrum are normalized to a sum up
to 1:
I =
Iraw∑
i I
raw
i
(1)
The normalized spectra are then subtracted to yield the difference spec-
trum D (Figure 2):
D = Iul − I l (2)
The detection of the characteristic pattern for the labeled fragment is
more robust in the first derivative of the difference spectrum (Figure 2).
Using a Savitzky-Golay filter with window size 5, a smoothed variant of the
first derivative of the difference spectrum can be calculated very efficiently.
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In this first derivative, isotopic enrichment will manifest as two positive peaks
separated by a negative peak for each labeled fragment (Figure 2). These
two subsequent maxima indicate the boundaries of a labeled fragment shifted
by 2 mass units due to the previous smoothing step. Therefore, by scanning
the first derivative for such patterns, all isotopically enriched fragments are
determined along with their m/z ranges. These ranges are required for the
next step to quantify the isotopic enrichment.
2.3. Quantification of isotopic enrichment
The detection of isotopic enrichment in the previous step was only qual-
itative. This enrichment now needs to be quantified in terms of an MID for
each labeled fragment. The raw MID observed in the mass spectrum of a
compound after stable isotope labeling is a combination of natural isotope
abundance and eventually from artificial isotopic enrichment as derived from
the tracer (Figure 3).
When analyzing stable isotope labeling data, usually only the artificial
enrichment derived from the tracer is of interest. Therefore, the raw mass
isotopomer distribution as obtained from the mass spectrum needs to be
corrected for natural isotope abundance. This is especially important in
GC-MS analyses where often a chemical derivatization is part of the sample
preparation, which introduces a large number of carbon or silicon atoms with
high natural isotope abundances.
In targeted stable isotope labeling analyses this correction for natural
isotope abundances is usually performed based on the theoretical MID as
expected from the elemental composition and the average natural isotope
abundance of each element [8]. However, this method is not applicable for
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non-targeted applications, since many compounds and fragments cannot be
identified and, thus, their elemental composition is not available.
Jennings and Matthews [27] presented an elegant method to correct raw
MIDs for natural isotope abundance through comparison with the mass spec-
trum of the unlabeled compound. An adaptation of this approach is applied
in NTFD.
In a 13C-labeling experiment, a compound with N carbons can contain
maximally up to N 13C isotopes from artificial tracer-derived enrichment.
The remaining, non-enriched atoms are subject to natural isotope abun-
dance (Figure 3A). The relative peak intensities in the mass spectrum of
such a compound represent the raw MID. The raw MID I l, of a fragment
of such a labeled compound arises from natural MIDs of its “artificial“ mass
isotopomers as depicted in Figure 3B. The relative abundances in I l are given
as the summation of the natural MIDs of all N+1 artificial mass isotopomers
M0, . . . ,MN , weighted by their relative abundance or the corrected MID M:
I l =

M00 ·M0
M01 ·M0 +M10 ·M1
...
M0n ·M0 +M1n−1 ·M1 + · · ·+Mn0 ·Mn
 (3)
=

M00 0 · · · 0
M01 M
1
0 · · · 0
...
... . . .
...
M0n M
1
n−1 · · · Mn0
 ·M =Mcorr ·M (4)
with Mab as the relative abundance of the bth natural mass isotopomer of
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the compound containing a tracer isotopes. If the correction matrixMcorr is
known, the corrected MID can be determined as
M =M−1corr · I l (5)
To correct the raw MID for natural isotope abundance, we need to know
the natural MIDsMa of the artificial mass isotopomers. As mentioned above,
they cannot be calculated from natural isotope abundances, since the elemen-
tal compositions is not available. However, we can obtain this information
from the unlabeled mass spectrum Iul. The first column of Mcorr, M0, is
the natural MID of the molecule, without any artificial enrichment. These
values are exactly the relative peak intensities in the mass spectrum Iul of
the unlabeled compound, leading us with (3) to:
Mcorr =

sul0 0 · · · 0
sul1 M
1
0 · · · 0
...
... . . .
...
suln M
1
n−1 · · · Mn0
 (6)
The remaining Mab can be replaced in a similar way. The mass spectra
of M1, . . . ,MN look similar to the unlabeled spectrum, but are shifted to
higher mass by 1, . . . , N (Figure 3). Furthermore, due to the fixed inclusion
of stable isotopes in M1, . . . ,MN , the M0 abundance will increase, and the
other mass isotopomer abundances will decrease. Since the relative natural
abundance of 13C and the number of carbons in most metabolites are rather
low, we assume that only the M0 and M1 abundances are affected by the
artificial enrichment, and neglect the insignificant changes in the abundances
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of higher mass isotopomers.
When a carbon atom in a molecule is artificially substituted by a 13C
isotope, this atom is no longer subject to natural isotope abundance, so that
theM0 abundance of the molecule increases and theM1 abundance decreases.
When a 13C isotopes are included, the ratio of M1 and M0 changes to [27]:
Ma1
Ma0
=
M01
M00
− a · p13C
p12C
(7)
with p12C and p13C as the average natural isotope abundances of 12C and
13C, respectively. We define this correction term as:
ca = a · p13C
p12C
(8)
Since we assume that the relative abundances of the heavier mass iso-
topomers remain constant, the M0 abundance increases by the same value
as the M1 abundance decreases. Therefore, their sum will not change:
Ma1 +M
a
0 =M
0
1 +M
0
0 (9)
Combining Equation 7, 8 and 9 provides a correction term M1corr to
obtain Ma0 from M0 as:
M01
M00
·Ma0 − ca ·Ma0 =M01 +M00 −Ma0 (10)
M01
M00
·Ma0 − ca ·Ma0 +Ma0 =M01 +M00 +M00 · ca −M00 · ca (11)
Ma0 =M
0
0 +
M00 · ca
M01
M00
+ 1− ca
=M00 +M1corr (12)
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Since the sum of M0 and M1 need to be constant (Equation 9), M1 needs
to decrease by the same amount as M0 increases:
Ma1 =M
0
1 −
M00 · ca
M01
M00
+ 1− ca
(13)
In summary, the natural mass isotopomer abundances Mab are given as:
Mab =

M0b , for a = 0 ∨ b > 1
M00 +M1corr, for a > 0 ∧ b = 0
M01 −M1corr, for a > 0 ∧ b = 1
(14)
This enables us to populate the correction matrixMcorr accordingly and
to determine the isotopic enrichment from Equation 5 by least-squares re-
gression without requiring any further knowledge on the given compound.
We explained this MID correction for the case of 13C labeling, but it can
be applied to any other isotopic element. Depending of the natural isotope
abundance of the isotopic element, aM2 correction may become necessary as
described in Jennings and Matthews [27]. Combined labeling from different
isotopic elements (e.g. 13C and 15N) can not be corrected using this approach,
since the contributions of the two isotopic species cannot be distinguished.
2.4. Quality measures
To judge the quality of the calculated MIDs, NTFD provides three quality
measures: the coefficient of determination, the sum of absolute values of the
relative mass isotopomer abundances, and confidence intervals of the relative
mass isotopomer abundances.
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2.4.1. Sum of absolute values
Theoretically, all relative mass isotopomer abundances should be within
the interval [0, 1] and their sum should be equal to one:
∑
i
Mi = 1 | Mi ∈ [0, 1] (15)
However, due to measurement errors, the regression can lead to negative
mass isotopomer abundances. The sum of the absolute values
∑
i
|Mi | (16)
can therefore be greater than one. This sum of absolute values provides
a first, simple, yet effective measure for the accuracy of the calculated MID.
The closer this value is to one, the more accurate are the MIDs.
2.4.2. Coefficient of determination
If replicate measurements of the labeled and unlabeled sample are avail-
able, the coefficient of determination R2 can be computed for every fragment.
This value is defined as
R2 =
∑n
i=1(Aˆi − A)2∑n
i=1(Ai − A)2
| R2 ∈ [0, 1] (17)
where Ai is the value of the given raw mass isotopomer abundance from the
ith measurement, Aˆi the corresponding regression value from the best fitting
MID, and A is the mean of the raw mass isotopomer abundances across all
measurements.
To put it less formally: R2 shows which fraction of the total variation in
the measured values can be explained by the linear regression model. Ideally,
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all variation is explained by the model (R2 = 1). In the worst case, none of
the variation can be explained by the regression model (R2 = 0).
2.4.3. Confidence intervals
The previous measures only provide an overall quality measure for the
whole MID. To judge the precision of the individual mass isotopomer abun-
dances, another measure is required. When replicate measurements are pro-
vided, confidence intervals for the relative mass isotopomer abundances can
be computed. The NTFD application reports 95% confidence intervals for
the mass isotopomer abundances.
3. Practical considerations
To obtain meaningful results from NTFD certain critical points need to be
taken into account. Starting with important experimental considerations we
will discuss how to avoid pitfalls in data analysis and highlight how common
problems can be solved.
3.1. Experimental considerations
A prerequisite for a NTFD analysis is a stable isotope labeling experiment
and a parallel experiment with the unlabeled tracer. To ensure that the
maximum number of labeled compounds is detected, both experiments must
be performed under the same conditions using the same cell line and growth
medium.
Although NTFD can work on single measurements, the use of replicate
measurements is strongly recommended. Replicates can reduce the effect
of analytical variations and will make the MID calculation more robust. If
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replicates are available, NTFD provides additional statistical quality mea-
sures for the calculated MIDs (subsection 2.4). Usually, three measurements
per experiment provide sufficiently good results.
3.1.1. Choice of isotopic tracer
For the design of a stable isotope labeling experiment, the proper choice
and amount of tracer is crucial. This choice completely depends on the
biological question asked [28]. For example, if the goal is to differentiate be-
tween metabolites produced and analytical background, all carbon substrates
should be replaced by their fully labeled analogues. To completely label an
organism a defined minimal medium, if it is available for the organism of
interest, is most conveniently used.
Generally, isotopic enrichment from any isotopic element can be analyzed
with NTFD, as long as there is no significant effect on M2 abundance, which
would not be corrected for. However, special care has to be taken in case of
deuterium. Deuteration is well-known to affect chromatographic retention,
and different isotopologues may be separated completely. This can turn out
problematic for two reasons: (1) the isotopologue mixture can be spread out
over multiple deconvoluted mass spectra and (2) the matching of the labeled
and unlabeled spectrum may not succeed due to shifts in retention time.
A combination of multiple tracers is generally possible, but will further
complicate the already difficult interpretation of the resulting MIDs. In most
cases it is advisable to distribute tracers among different experiments, except
if the goal is to completely label an organism.
Once the tracer is chosen, the second important decision is the ratio at
which it is introduced. On the one hand, a higher tracer abundance will lead
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to higher and therefore better detection of isotopic enrichment in downstream
metabolites. On the other hand, complete isotopic enrichment may lead to
very dissimilar mass spectra from the labeled and unlabeled sample which
cannot be matched properly. In such a case labeled compounds may be
overseen, since the detection of isotopic enrichment by NTFD depends on
the correct matching of these mass spectra. However, in most cases, NTFD
works well with higher isotopic enrichment.
An important parameter for subsequent data analysis is the incubation
time with the selected tracer. For many applications, it is desirable that
the system reaches isotopic steady-state, meaning that isotopic labeling does
not change over time. The required incubation time can range from several
minutes to several days and needs to determined from stable isotope labeling
time-series of the specific system of interest. With in vivo labeling of com-
plex organisms isotopic steady-state may not be achievable at all. However,
isotopic non-steady-state does not affect the detection and quantification of
isotopic enrichment per se, but needs to be accounted for during interpreta-
tion of the resulting MIDs.
3.1.2. GC-MS measurements
Ideally, the labeled and the unlabeled samples are measured subsequently
on the same instrument. Standard GC-MS temperature programs and set-
tings for the analysis of trimethylsilyl (TMS) derivatives of metabolites can
be found here [29]. In case measurements are from different runs or instru-
ments, retention time stability must be ensured. To aid compound matching,
a calibration mixture such as an n-alkane mix (usually C10 to C40) should be
measured to calculate the Kováts retention index [30].
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The usual metabolomics quality controls, like e.g. blank samples, should
be included in the measurement as a quality control measure. If a compound
that is isotopically enriched is also found to be present in any blank mea-
surements, the respective MIDs need to be interpreted with caution, since
the relative M0 abundance may be overestimated due to label dilution from
the exogenous compound.
A similar problem is caused by detector saturation. If signal intensities
lie outside the linear range of the detector, or if the detector is fully satu-
rated, signal intensities are skewed or clipped. The relative mass isotopomer
abundance determined by the respective ion may then be underestimated.
This can, depending on the extent, strongly impact MID calculation for the
respective fragments.
3.2. Data analysis
As with most non-targeted methods, NTFD data analysis can be tedious
and frustrating if the wrong parameters are applied. In the following section,
the most important steps and the respective parameters controlling a suc-
cessful analysis are explained. The NTFD implementation is freely available
for Linux and Windows operating systems. The software and detailed doc-
umentation of the user interface, along with sample data and a step-by-step
tutorial are available at http://ntfd.mit.edu. Briefly, there are four dif-
ferent dialogs the user can interact with (Figure 4): (1) Selection of labeled
measurements in netCDF or MetaboliteDetector [31] format. (2) Selection of
unlabeled measurements in netCDF or MetaboliteDetector format. (3) The
settings tab containing the important parameters for compound and label
detection. (4) The result tab showing the list of detected labeled compounds
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and their respective fragment MIDs.
3.2.1. Data preprocessing
Before starting an NTFD analysis, it is important to check the quality of
all chromatograms. The outcome of the analysis depends heavily on the cor-
rect preprocessing of the raw data. Before NTFD can start to detect isotopi-
cally enriched compounds, a peak picking and mass spectral deconvolution
has to be performed. The raw data is scanned for peaks in the signal inten-
sity which cross a certain threshold of absolute intensity and signal-to-noise
ratio. Any signal below this threshold is discarded. All peaks detected at
this stage are used for mass spectral deconvolution, that is they are grouped
to specific mass spectra according to their retention time. A narrower de-
convolution window will ensure that closely eluting peaks are separated, and
a broader deconvolution window is necessary for broad peaks or for deuter-
ated compounds where different isotopologues can elute at slightly different
retention times.
This stage is very important, because it forms the basis on which all sub-
sequent label detection will be performed. Therefore, the parameters should
be well chosen. If the peak picking is too sensitive it will increase processing
time and may yield an increased number of false positives. On the other hand
this step needs to be sensitive enough to detect low-intensity isotopic peaks
(Figure 5). To avoid a high number of false positives during the detection
of isotopic enrichment, low quality spectra are best filtered out already after
deconvolution. For example most EI-MS spectra with less than 20 peaks are
usually of low quality. Although NTFD can directly process netCDF files,
perform peak picking and spectrum deconvolution and the default parame-
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ters will often fit, it is advisable to check the settings used within a dedicated
analysis software such as MetaboliteDetector [31]. The advantage of Metabo-
liteDetector is that the results of these preprocessing steps can be visualized,
therefore, effects of different parameters can be evaluated more easily. More-
over, MetaboliteDetector can calculate the Kováts retention index [30] and
NTFD can directly use the generated files.
Critical parameters controlling this step (Figure 4):
Peak threshold The minimum signal-to-noise ratio for every chromato-
graphic peak (default value: 5).
Min Peak height The peak threshold in absolute signal intensity (default
value: 5).
Deconvolution width The number of scans by which chromatographic
peaks are allowed to differ to still be considered as part of the same
mass spectrum (default value: 5).
Redetect all compounds The peak detection and spectrum deconvolution
step only has to be performed once. However, if any of the settings are
updated, it has to be repeated for all measurements.
3.2.2. Detection and quantification of isotopic enrichment
While the detection of isotopically enriched fragments mainly depends on
the correct peak picking and deconvolution parameters described above, the
correct quantification additionally requires a correct M1 correction (subsec-
tion 2.3).
Critical parameters controlling this step (Figure 4):
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M1 correction Needs to be adjusted for the isotopic element used in the
tracer (Equation 7). Only A+1 elements are currently supported. This
value is the ratio of the natural relative abundance of the heavy ph and
light pl isotope times 100:
M1corr =
ph
pl
Natural isotope abundances can be found in [32]. Most common cor-
rection values are:
M1corr13C =
p13C
p12C
=
0.0107
0.9893
= 0.0108, for 13C labeling
M1corr15N =
p15N
p14N
=
0.00364
0.99636
= 0.00365, for 15N labeling
M1corr2H =
p2H
p1H
=
0.000115
0.999885
= 0.000115, for 2H labeling
3.2.3. Data filtering & quality control
One important part of data analysis is to exclude false positives from the
result set. Although NTFD offers several different parameters to exclude
false positively identified fragments or fragments with incorrectly calculated
MIDs, it is absolutely essential to go back and consult the original data be-
fore interpreting the results. For example, fragment overlap, which impairs
MID calculation, can be easily identified by inspecting the unlabeled mass
spectrum. Furthermore, compounds which have not been detected as isotopi-
cally enriched need to be carefully checked before interpreting any negative
results.
Critical parameters controlling this step (Figure 4):
Tuning the following parameters will suffice for most applications. For
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additional Advanced parameters Figure 4, which are described in the NTFD
documentation, the default values should be used.
Minimum R2 Results can be filtered by their R2. All fragments with a
coefficient of determination below this threshold will be discarded.
Maximal fragment deviation All fragments for which the sum of abso-
lute values of relative mass isotopomer abundances deviates from 1 by
more than this value will be discarded.
Required number of labeled fragments Compounds with less labeled frag-
ments will be discarded.
Minimal and maximal isotopic enrichment Compounds for which the
detected enrichment is very low are often false positives; moreover iso-
topic enrichment cannot be higher than the original tracer ratio. Re-
sults can be filtered for min ≤ 1−M0 ≤ max.
3.2.4. Controlling sensitivity and specificity
The above described parameters allow the user to adjust the sensitivity
and specificity of the label detection to the specific purpose of the study.
For example, if the aim of the study is to validate active metabolic path-
ways, the information on isotopic enrichment per se is of more interest
than the accuracy of the quantitative enrichment. In that case parame-
ters should be optimized towards high sensitivity. Specifically the follow-
ing settings could be applied: Required number of labeled fragments = 1,
Minimal isotopic enrichment = 1, R2 = 0.9, andMaximal fragment deviation =
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0.2. As described above, it is of utterly high importance with these sensi-
tive settings to carefully check the results for false positives. However, if
the goal of the study is to quantitatively compare MIDs between two con-
ditions, settings should be stricter. As a rule of thumb, the R2 should be
above 0.98 and the sum of absolute values should be less than 1.02 for MID
interpretation. To get reliable MIDs the following settings could be used:
Required number of labeled fragments = 2, Minimal isotopic enrichment =
5, R2 = 0.98, and Maximal fragment deviation = 0.02. Nevertheless, it
is advisable to start with sensitive settings and optimize towards the best
trade-off between specificity and sensitivity.
4. NTFD applications
Most tools for the non-targeted detection of stable isotope labeling have
been developed only recently. Therefore, it is not surprising that there have
not been many non-targeted stable isotope labeling analyses yet. We will
present previously published as well as additional potential applications of
non-targeted detection of isotope labeling.
4.1. Detecting genuine metabolites
In non-targeted metabolomics one is often confronted with a large number
of chromatographic - mass spectrometric features where it is unclear whether
these are artifacts from sample preparation, compounds from complex growth
media, or native metabolites. After cultivating an organism on fully 13C
enriched substrates, one can be sure that any carbon-containing compound
that is not isotopically enriched is not produced by the organism but is of
exogenous origin. Therefore, non-targeted detection of stable isotope labeling
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has most commonly been applied to distinguish metabolites from analytical
background and to determine mass spectrometric ions originating from the
labeled and the unlabeled compound to use them for relative quantification
of metabolite levels [33–37].
4.2. 15N tracing
Not only 13C, but also 15N labeling can provide interesting insights into
metabolism. For mammalian cells, glutamine and glutamic acid are the main
nitrogen sources. Therefore, [U-15N]glutamine can be applied as a tracer to
label most nitrogen containing metabolites in mammalian cells, which can in
turn be detected with NTFD. In a more quantitative approach, Gaglio et al.
[38] analyzed MIDs after [α-15N]glutamine labeling in a non-targeted manner
to reveal altered glutamine utilization in K-Ras transformed cells.
4.3. Analysis of mass spectrometric fragmentation
The non-targeted detection of stable isotope labeling in mass spectromet-
ric fragments can be interesting for compounds with unknown fragmentation
pathways. MIDs of individual fragments provide valuable information on el-
emental composition and origin of the respective atoms. Moreover, the MID
can reveal overlapping fragments of the same mass [9]. For this purpose,
we embedded the NTFD algorithm into the Fragment Formula Calculator
(FFC) software [9]. FFC determines elemental composition and potential
substructures of mass spectrometric fragment ions by a graph-based com-
binatorial approach. It can include information from stable isotope labeled
spectra to rule out certain combinations.
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4.4. Metabolism of xenobiotics
In pharmaceutical research, absorption, distribution, metabolism, and
excretion (ADME) studies are conducted to determine the fate of a drug
or other xenobiotics within an organism. Such studies often use radiola-
beled compounds or analyze stable isotope labeling in a targeted manner
[39]. NTFD can provide insights into metabolism of xenobiotics without the
need of radiolabeled compounds. After applying a stable isotope labeled drug
to an organism, NTFD can be used to detect all measured drug metabolites
in a non-targeted manner.
4.5. Model validation
Genome-scale metabolic networks [40] are used for the stoichiometric
modeling of metabolism to infer intracellular metabolic fluxes [41]. These
metabolic networks are generated from transcriptomics or proteomics data.
However, the presence of a certain mRNA or even protein does not tell any-
thing about actual enzymatic activities. To this end, non-targeted tracer fate
analyses can be used to determine metabolic pathways that are active under
any given conditions. Furthermore, NTFD can be used to test the com-
prehensiveness of a metabolic network reconstruction. If a reconstruction is
comprehensive, all isotopically enriched compounds should be identifiable.
Otherwise, additional compounds need to be included.
4.6. Tracing functional groups
Dedicated tracers can be used in combination with NTFD to trace func-
tional groups through metabolism or detect products of specific types of
reactions. Methylation reactions and associated one-carbon metabolism are
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important for many anabolic processes as well as for detoxification of many
xenobiotics and inactivation of endogenous substances such as catecholamines
[42]. The methyl groups are derived directly or indirectly from methyl-
tetrahydrofolate. The main contributor to this pool is serine, or more specif-
ically C-3 of serine. Therefore, [3-13C]serine can be applied to label the
one-carbon pool and all methylation products.
4.7. Cofactor tracing
Lewis et al. [41] and Fan et al. [43] used deuterated glucose tracers to
selectively label the cellular NADH or NADPH pool. [3-2H]glucose specif-
ically labels NADPH that is generated in the pentose phosphate pathway.
Other glucose molecules that are undergoing glycolysis and are not enter-
ing the pentose phosphate pathway will lose the deuterium label to water.
The deuterium from the labeled NADPH will be transferred as hydride ion
by NADPH-dependent enzymes, mostly reductases and dehydrogenases, to
their substrates. These products can then be detected by NTFD in a non-
targeted manner. Analogously, [4-2H]glucose can be used to label the cellular
NADH pool and to trace NADH-dependent reductions [41].
4.8. Non-targeted metabolic turnover analysis
Non-targeted metabolic turnover analysis, was presented by Nakayama
et al. [44] to detect metabolic pathways affected by external perturbations.
To this end, they performed principal component analysis (PCA) on a time-
series of relative mass isotopomer abundances. Such analyses can reveal
metabolic vicinity and group unidentified compounds into discrete pathways.
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More such novel workflows are needed to make full use of the information
contained in metabolome-wide stable isotope labeling datasets.
5. Summary & Outlook
The field of non-targeted stable isotope labeling analysis is still very young
and algorithms and tools for the automated metabolome-wide detection of
isotopic enrichment have only become available in recent years. Here we pre-
sented the NTFD algorithm, explained how NTFD can be used to determine
isotopic enrichment in a non-targeted manner, and finally highlighted poten-
tial applications. The advancement of current tools and the development of
novel workflows will help to benefit from the high potential of non-targeted
stable isotope labeling data to provide further insights into the structure and
dynamics of metabolic networks.
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7. Figure Legends
Figure 1: The NTFD algorithm operates on GC-EI-MS measurements of an isotopically
enriched and non-enriched sample. For each compound, mass spectra from both mea-
surements are paired. Isotopically enriched fragments are determined from characteristic
patterns in the difference spectrum. For each of these enriched fragments the MID is
determined.
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Figure 2: NTFD detects labeled fragments in the difference spectrum of mass spectra
derived from a potentially isotopically enriched and non-enriched compound.
A: Mass spectrum of a fragment of the unlabeled compound and its labeled analogue,
normalized to total ion current (TIC). Isotopic enrichment leads to characteristic peak
patterns in the difference spectrum and its first derivative. Fragment boundaries are
detected in the first derivative of the smoothed difference spectrum. The boundaries are
shifted by 2 units due to the applied smoothing algorithm.
B: First derivative ( dDd(m/z) ) of the full difference spectrum of glutamine 4TMS. Two positive
peaks, separated by a negative peak, mark an isotopically enriched fragment.
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Figure 3: Artificial isotopic enrichment and natural isotope abundance determine isotopic
peak patterns in a mass spectrum after stable isotope labeling experiments. Stable isotope
labeling of a compound with two enrichable positions.
A: The mass spectra of all three mass isotopomers that can arise from stable isotope
labeling show isotopic peaks due to the natural isotope abundance in the non-enriched
positions. The natural isotope contribution, i.e. the relative intensity of the M+1 peak,
decreases with increasing artificial enrichment. The relative M+0 intensity increases by
the same value. Filled circle: heavy isotope; empty circle: light isotope. Signal intensity
is scaled to base peak intensity (BPI).
B: After a stable isotope labeling experiment the mass spectrum of the given compound
is a mixture of the natural MIDs of the three artificial mass isotopomers. This spectrum
is the average of M0, M1 and M2, weighted by the corrected MID M .
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Figure 4: Graphical user interface of the NTFD implementation [12]. The program is
freely available for Linux and Windows operating systems. After GC-MS measurement,
(1) the files of the isotopically enriched and (2) the non-enriched samples need to be
selected, (3) Parameters for the detection and quantification of isotopic enrichment need
to be adjusted, then (4) NTFD will determine all isotopically enriched compounds and
fragments along with their MIDs.
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Figure 5: Proper peak picking and mass spectrum deconvolution is a prerequisite for
meaningful NTFD results.
B,C: Insensitive peak detection will miss isotopic peaks or whole fragments and impair
calculated MIDs.
D-F: Deconvolution settings need to be adjusted to properly extract pure mass spectra
(D,E) of close-by chromatographic peaks of coeluting compounds (A). If deconvolution
width is set too high, close-by chromatographic peaks will be assigned incorrectly to a
single compound (F) and overlapping fragments will give rise to misleading MIDs.
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Figure 6: Quality measures for MID determination. MIDs of 2-oxoglutaric acid 2TMS
1MeOX determined after incubating mammalian cells with [U-13C]glutamine.
A: Fragment m/z 244: High quality mass spectra without fragment overlap yield well
determined MIDs (small confidence intervals, R2 ≈ 1.00, ∑ |M | ≈ 1.00).
B: Overlapping fragments impair calculated MIDs. Fragments m/z 198 m/z 202 are
overlapping causing a high negative M9 abundance in the determined MID. Such MIDs
are unusable, despite low confidence intervals and high R2.
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